Table 1.
Genotype | Number of mice | Number of mice with hyperplastic lesions | Number of mice with adenocarcinomas | Number of hyperplastic lesions | Number of adenocarcinomas |
---|---|---|---|---|---|
Control# | 20 | 0 | 0 | 0 | 0 |
Tgfbr2IEKO | 20 | 0 | 0 | 0 | 0 |
PtenIEKO | 39 | 2€ | 1λ | 3 | 1 |
PtenIEKO; Tgfbr2IEKO | 43 | 4μ,£.¥ | 35δ,&.¥ | 4 | 49 |
Control = wild-type mice, matched strain background
P = 0.54, PtenIEKO (2/39) vs. Control (0/20), Fisher’s exact test
P = 1.0, PtenIEKO (1/39) vs. Control (0/20), Fisher’s exact test
P = 0.30, PtenIEKO; Tgfbr2IEKO (4/43) vs. Control (0/20), Fisher’s exact test
P = 0.68, PtenIEKO; Tgfbr2IEKO (4/43) vs. PtenIEKO (2/39), Fisher’s exact test
P < 0.0001, PtenIEKO; Tgfbr2IEKO (35/43) vs. Control (0/20), Fisher’s exact test
P < 0.0001, PtenIEKO; Tgfbr2IEKO (35/43) vs. PtenIEKO (1/39), Fisher’s exact test
N=2 mice developed one adenocarcinoma and one hyperplastic lesion with dysplasia